These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 11431245

  • 1. Venlafaxine-induced hair loss.
    Pitchot W, Ansseau M.
    Am J Psychiatry; 2001 Jul; 158(7):1159-60. PubMed ID: 11431245
    [No Abstract] [Full Text] [Related]

  • 2. Venlafaxine withdrawal reactions.
    Louie AK, Lannon RA, Kirsch MA, Lewis TB.
    Am J Psychiatry; 1996 Dec; 153(12):1652. PubMed ID: 8942467
    [No Abstract] [Full Text] [Related]

  • 3. Benztropine in the treatment of venlafaxine-induced sweating.
    Garber A, Gregory RJ.
    J Clin Psychiatry; 1997 Apr; 58(4):176-7. PubMed ID: 9164433
    [No Abstract] [Full Text] [Related]

  • 4. Venlafaxine-associated hypomania in unipolar depression.
    Chand PK, Kalyani GS, Murthy P.
    Can J Psychiatry; 2004 Jul; 49(7):496. PubMed ID: 15362257
    [No Abstract] [Full Text] [Related]

  • 5. Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
    Bertolín-Guillén JM, Climent-Díaz B, Navarré-Gimeno A.
    Eur Psychiatry; 2004 Nov; 19(7):456-7. PubMed ID: 15504661
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of venlafaxine discontinuation symptoms with ondansetron.
    Raby WN.
    J Clin Psychiatry; 1998 Nov; 59(11):621-2. PubMed ID: 9862610
    [No Abstract] [Full Text] [Related]

  • 7. Withdrawal syndrome after discontinuation of venlafaxine.
    Agelink MW, Zitzelsberger A, Klieser E.
    Am J Psychiatry; 1997 Oct; 154(10):1473-4. PubMed ID: 9326838
    [No Abstract] [Full Text] [Related]

  • 8. Serotonin syndrome induced by administration of venlafaxine and phenelzine.
    Heisler MA, Guidry JR, Arnecke B.
    Ann Pharmacother; 1996 Jan; 30(1):84. PubMed ID: 8773172
    [No Abstract] [Full Text] [Related]

  • 9. Extended-release venlafaxine-induced alopecia.
    Pereira CE, Goldman-Levine JD.
    Ann Pharmacother; 2007 Jun; 41(6):1084. PubMed ID: 17519298
    [No Abstract] [Full Text] [Related]

  • 10. Venlafaxine-induced delirium.
    Howe C, Ravasia S.
    Can J Psychiatry; 2003 Mar; 48(2):129. PubMed ID: 12655917
    [No Abstract] [Full Text] [Related]

  • 11. Onset of confusion in the context of late-life depression.
    Mulsant BH.
    J Psychiatry Neurosci; 2007 Mar; 32(2):152. PubMed ID: 17353943
    [No Abstract] [Full Text] [Related]

  • 12. Flushing in a menopausal woman taking venlafaxine.
    Grady-Weliky TA, Hartmann DM.
    Am J Psychiatry; 2001 Aug; 158(8):1330. PubMed ID: 11481177
    [No Abstract] [Full Text] [Related]

  • 13. Venlafaxine-induced urinary incontinence resolved after switching to sertraline.
    Polimeni G, Salvo F, Cutroneo P, Nati G, Russo A, Giustini ES, Spina E.
    Clin Neuropharmacol; 2005 Aug; 28(5):247-8. PubMed ID: 16239768
    [Abstract] [Full Text] [Related]

  • 14. Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
    Anghelescu I, Klawe C, Himmerich H, Szegedi A.
    J Clin Psychopharmacol; 2001 Aug; 21(4):462-4. PubMed ID: 11476137
    [No Abstract] [Full Text] [Related]

  • 15. Venlafaxine versus fluoxetine.
    Paton C.
    J Clin Psychiatry; 1999 Oct; 60(10):708. PubMed ID: 10549691
    [No Abstract] [Full Text] [Related]

  • 16. Antidepressant options: venlafaxine in perspective.
    Thase ME.
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):10S-18S; discussion 18S-20S. PubMed ID: 8784644
    [Abstract] [Full Text] [Related]

  • 17. Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association.
    Liberek C, Aubry JM, Baud P.
    Therapie; 2006 Jun; 61(6):531-3. PubMed ID: 17348610
    [No Abstract] [Full Text] [Related]

  • 18. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG, Cold JA, Jann MW.
    Pharmacotherapy; 1997 Jun; 17(3):511-30. PubMed ID: 9165554
    [Abstract] [Full Text] [Related]

  • 19. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
    Fava M, Mulroy R, Alpert J, Nierenberg AA, Rosenbaum JF.
    Am J Psychiatry; 1997 Dec; 154(12):1760-2. PubMed ID: 9396960
    [Abstract] [Full Text] [Related]

  • 20. Venlafaxine-induced hyponatremia.
    Gupta AK, Saravay SM.
    J Clin Psychopharmacol; 1997 Jun; 17(3):223-5. PubMed ID: 9169969
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.